ACC 2012 schedule: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (11 intermediate revisions by the same user not shown) | |||
| Line 7: | Line 7: | ||
==Click on Date for Detailed Schedule== | ==Click on Date for Detailed Schedule== | ||
[[{{PAGENAME}}#Saturday March 24, 2012|Saturday March 24, 2012]] | [[{{PAGENAME}}#Saturday March 24, 2012|Saturday March 24, 2012]] | ||
| Line 19: | Line 17: | ||
---- | ---- | ||
| Line 50: | Line 25: | ||
===8:30 AM=== | ===8:30 AM=== | ||
''8:30 AM - 9:00 AM'' | |||
*'''Interviewee:''' Dr. William S. Weintraub | |||
*'''Topic:''' Survival after PCI or CABG in Older Patients with Stable Multivessel Coronary Disease: Results from the ACCF-STS Database Collaboration on the Comparative Effectiveness of Revascularization Strategies | |||
*'''Embargo lift:''' 8:00 AM Tuesday, March 27, 2012 | |||
===9:00 AM=== | ===9:00 AM=== | ||
| Line 59: | Line 37: | ||
===10:00 AM=== | ===10:00 AM=== | ||
''10:00 AM - 10:30 AM'' | |||
*'''Interviewee:''' Dr. Shinya Goto | |||
*'''Topic:''' Apixaban versus Warfarin in Patients with Atrial Fibrilation - Sub-analysis in Japanese patients from the ARISTOTLE Study | |||
*'''Embargo lift:''' 8:30 AM on Sunday, March 18, 2012 | |||
===10:30 AM=== | ===10:30 AM=== | ||
| Line 71: | Line 52: | ||
*'''Interviewee:''' Dr. Udo Hoffmann | *'''Interviewee:''' Dr. Udo Hoffmann | ||
*'''Topic:''' Multicenter Randomized Comparative Effectiveness Trial of Cardiac CT vs Alternative Triage Strategies in Acute Chest Pain Patients in the Emergency Department: Results from the ROMICAT II Trial | *'''Topic:''' Multicenter Randomized Comparative Effectiveness Trial of Cardiac CT vs Alternative Triage Strategies in Acute Chest Pain Patients in the Emergency Department: Results from the ROMICAT II Trial | ||
*'''Embargo lift:''' | *'''Embargo lift:''' 8:00 AM on Tuesday, March 27, 2012 | ||
===11:30 AM=== | ===11:30 AM=== | ||
| Line 83: | Line 64: | ||
*'''Interviewee:''' Dr. Andre Lamy | *'''Interviewee:''' Dr. Andre Lamy | ||
*'''Topic:''' CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study | *'''Topic:''' CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study | ||
*'''Embargo lift:''' | *'''Embargo lift:''' 8:00 AM on Monday, March 26, 2012 | ||
===12:30 PM=== | ===12:30 PM=== | ||
| Line 101: | Line 82: | ||
===9:00 AM=== | ===9:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===10:30 AM=== | ===10:30 AM=== | ||
| Line 113: | Line 91: | ||
===11:30 AM=== | ===11:30 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===2:00 PM=== | ===2:00 PM=== | ||
''2:00 PM - 2:30 PM'' | ''2:00 PM - 2:30 PM'' | ||
*'''Interviewee:''' Dr. Otavio Berwanger | *'''Interviewee:''' Dr. Otavio Berwanger and Dr. Renato Lopes | ||
*'''Topic:''' A Multifaceted Intervention to Narrow the Evidence-Based Gap in the Treatment of Acute Coronary Syndromes: Main Results from the BRIDGE-ACS Cluster Randomized Trial | *'''Topic:''' A Multifaceted Intervention to Narrow the Evidence-Based Gap in the Treatment of Acute Coronary Syndromes: Main Results from the BRIDGE-ACS Cluster Randomized Trial | ||
*'''Embargo lift:''' | *'''Embargo lift:''' 8:00 AM on Sunday, March 25, 2012 | ||
===2:30 PM=== | ===2:30 PM=== | ||
| Line 127: | Line 103: | ||
*'''Interviewee:''' Dr. Mohsen Sharifi | *'''Interviewee:''' Dr. Mohsen Sharifi | ||
*'''Topic:''' Moderate Pulmonary Embolism Treated with Thrombolysis (MOPETT Study) | *'''Topic:''' Moderate Pulmonary Embolism Treated with Thrombolysis (MOPETT Study) | ||
*'''Embargo lift:''' | *'''Embargo lift:''' 10:00 AM on Tuesday, March 27, 2012 | ||
===3:00 PM=== | ===3:00 PM=== | ||
| Line 133: | Line 109: | ||
*'''Interviewee:''' Dr. Brian Anthony Ference | *'''Interviewee:''' Dr. Brian Anthony Ference | ||
*'''Topic:''' A Mendelian Randomized Controlled Trial of Long Term Reduction in Low-Density Lipoprotein Cholesterol Beginning Early in Life | *'''Topic:''' A Mendelian Randomized Controlled Trial of Long Term Reduction in Low-Density Lipoprotein Cholesterol Beginning Early in Life | ||
*'''Embargo lift:''' Monday, March 26, 2012 | *'''Embargo lift:''' 10:30 AM Monday, March 26, 2012 | ||
===3:30 PM=== | ===3:30 PM=== | ||
| Line 139: | Line 115: | ||
*'''Interviewee:''' Dr. Harry Roger Buller | *'''Interviewee:''' Dr. Harry Roger Buller | ||
*'''Topic:''' Oral Rivaroxaban Alone for Symptomatic Pulmonary Embolism: The EINSTEIN PE Study | *'''Topic:''' Oral Rivaroxaban Alone for Symptomatic Pulmonary Embolism: The EINSTEIN PE Study | ||
*'''Embargo lift:''' | *'''Embargo lift:''' 8:00 AM on Monday, March 26, 2012 | ||
===4:00 PM=== | ===4:00 PM=== | ||
| Line 145: | Line 121: | ||
*'''Interviewee:''' Dr. Michele Brignole | *'''Interviewee:''' Dr. Michele Brignole | ||
*'''Topic:''' Pacemaker Therapy in Patients with Neurally-mediated Syncope and Documented Asystole | *'''Topic:''' Pacemaker Therapy in Patients with Neurally-mediated Syncope and Documented Asystole | ||
*'''Embargo lift:''' Monday, March 26, 2012 | *'''Embargo lift:''' 10:30 AM Monday, March 26, 2012 | ||
===4:30 PM=== | ===4:30 PM=== | ||
| Line 166: | Line 142: | ||
*'''Interviewee:''' Dr. Henry P. Selker | *'''Interviewee:''' Dr. Henry P. Selker | ||
*'''Topic:''' Results of the IMMEDIATE (Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care) Trial: A Double-Blind Randomized Controlled Trial of Intravenous Glucose, Insulin, and Potassium (GIK)for Acute Coronary Syndromes in Emergency Medical Services | *'''Topic:''' Results of the IMMEDIATE (Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care) Trial: A Double-Blind Randomized Controlled Trial of Intravenous Glucose, Insulin, and Potassium (GIK)for Acute Coronary Syndromes in Emergency Medical Services | ||
*'''Embargo lift:''' Tuesday, March 27, 2012 | *'''Embargo lift:''' 8:00 AM Tuesday, March 27, 2012 | ||
===9:30 AM=== | ===9:30 AM=== | ||
''9:30 AM - 10:00 AM'' | |||
*'''Interviewee:''' Dr. Sergio Leonardi and Dr. Pierluigi Tricoci | |||
*'''Topic:''' ACC Wrap-Up in Italian | |||
===10:00 AM=== | ===10:00 AM=== | ||
| Line 196: | Line 174: | ||
*'''Interviewee:''' Dr. Hyo-Soo Kim | *'''Interviewee:''' Dr. Hyo-Soo Kim | ||
*'''Topic:''' Randomized Comparison of Adding Cilostazol Versus Doubling the Dose of Clopidogrel after Receiving Percutaneous Coronary Intervention: The HOST-ASSURE Randomized Trial | *'''Topic:''' Randomized Comparison of Adding Cilostazol Versus Doubling the Dose of Clopidogrel after Receiving Percutaneous Coronary Intervention: The HOST-ASSURE Randomized Trial | ||
*'''Embargo lift:''' Sunday, March 25, 2012 | *'''Embargo lift:''' 8:00 AM Sunday, March 25, 2012 | ||
===1:00 PM=== | ===1:00 PM=== | ||
''1:00 PM - 1:30 PM'' | ''1:00 PM - 1:30 PM'' | ||
*'''Interviewee:''' Dr. Renato Lopes | *'''Interviewee:''' Dr. Renato Lopes | ||
*'''Topic:''' ACC Wrap-Up in Portuguese | *'''Topic 1:''' ACC Wrap-Up in Portuguese | ||
*'''Topic 2:''' CHADS Subgroup Analysis from ARISTOTLE | |||
*'''Embargo lift:''' Sunday, March 25, 2012 | |||
| Line 212: | Line 192: | ||
===8:30 AM=== | ===8:30 AM=== | ||
''8:30 AM - 9:00 AM'' | |||
*'''Interviewee:''' Dr. Sergio Leonardi and Dr. Aldo Pietro Maggioni | |||
*'''Topic:''' ACC Wrap-Up in Italian | |||
===9:00 AM=== | ===9:00 AM=== | ||
| Line 218: | Line 200: | ||
===9:30 AM=== | ===9:30 AM=== | ||
''9:30 AM - 10:00 AM'' | |||
*'''Interviewee:''' Dr. Freek W.A. Verheugt | |||
*'''Topic:''' ACC Wrap-Up from a Dutch Perspective | |||
===10:00 AM=== | ===10:00 AM=== | ||
| Line 229: | Line 213: | ||
===11:00 AM=== | ===11:00 AM=== | ||
''11:00 AM - 11:30 AM'' | |||
*'''Interviewee:''' Dr. Hisao Ogawa | |||
*'''Topic:''' ACC Wrap-Up in Japanese | |||
===11:30 AM=== | ===11:30 AM=== | ||
Latest revision as of 12:57, 21 March 2012
Here is the page we will use to coordinate the TV events at ACC 2012. Open time slots are indicated below in red.
Filming location TBD.
Click on Date for Detailed Schedule
Saturday March 24, 2012
8:00 AM
OPEN TIME SLOT
8:30 AM
8:30 AM - 9:00 AM
- Interviewee: Dr. William S. Weintraub
- Topic: Survival after PCI or CABG in Older Patients with Stable Multivessel Coronary Disease: Results from the ACCF-STS Database Collaboration on the Comparative Effectiveness of Revascularization Strategies
- Embargo lift: 8:00 AM Tuesday, March 27, 2012
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Dr. Shinya Goto
- Topic: Apixaban versus Warfarin in Patients with Atrial Fibrilation - Sub-analysis in Japanese patients from the ARISTOTLE Study
- Embargo lift: 8:30 AM on Sunday, March 18, 2012
10:30 AM
10:30 AM - 11:00 AM
- Interviewee: Dr. Gregg W. Stone
- Topic: INFUSE-AMI: A 2x2 Factorial, Multicenter, Prospective, Randomized Evaluation of Intracoronary Abciximab and Aspiration Thrombectomy in Patients Undergoing Primary PCI for Anterior STEMI
- Embargo lift: 9:00 AM on Sunday, March 25, 2012
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Udo Hoffmann
- Topic: Multicenter Randomized Comparative Effectiveness Trial of Cardiac CT vs Alternative Triage Strategies in Acute Chest Pain Patients in the Emergency Department: Results from the ROMICAT II Trial
- Embargo lift: 8:00 AM on Tuesday, March 27, 2012
11:30 AM
11:30 AM - 12:00 PM
- Interviewee: Dr. James McKenney
- Topic: A Randomized, Double Blind, Placebo-controlled Trial of the Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, REGN727/SAR236553, in Patients with Primary Hypercholesterolemia (NCT: 01288443)
- Embargo lift: 11:14 AM on Monday, March 26, 2012
12:00 PM
12:00 PM - 12:30 PM
- Interviewee: Dr. Andre Lamy
- Topic: CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study
- Embargo lift: 8:00 AM on Monday, March 26, 2012
12:30 PM
OPEN TIME SLOT
Sunday March 25, 2012
8:00 AM
OPEN TIME SLOT
8:30 AM
8:30 AM - 9:00 AM
- Interviewee: Dr. Emerson C. Perin
- Topic: Effect of Transendocardial Autologous Bone Marrow Mononuclear Cell Delivery on Functional Capacity, Left Ventricular Function and Perfusion in Chronic Ischemic Heart Failure: The FOCUS Randomized Trial
- Embargo lift: 9:30 AM on Saturday, March 24, 2012
9:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Otavio Berwanger and Dr. Renato Lopes
- Topic: A Multifaceted Intervention to Narrow the Evidence-Based Gap in the Treatment of Acute Coronary Syndromes: Main Results from the BRIDGE-ACS Cluster Randomized Trial
- Embargo lift: 8:00 AM on Sunday, March 25, 2012
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. Mohsen Sharifi
- Topic: Moderate Pulmonary Embolism Treated with Thrombolysis (MOPETT Study)
- Embargo lift: 10:00 AM on Tuesday, March 27, 2012
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: Dr. Brian Anthony Ference
- Topic: A Mendelian Randomized Controlled Trial of Long Term Reduction in Low-Density Lipoprotein Cholesterol Beginning Early in Life
- Embargo lift: 10:30 AM Monday, March 26, 2012
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Harry Roger Buller
- Topic: Oral Rivaroxaban Alone for Symptomatic Pulmonary Embolism: The EINSTEIN PE Study
- Embargo lift: 8:00 AM on Monday, March 26, 2012
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Michele Brignole
- Topic: Pacemaker Therapy in Patients with Neurally-mediated Syncope and Documented Asystole
- Embargo lift: 10:30 AM Monday, March 26, 2012
4:30 PM
4:30 PM - 5:30 PM
- Interviewee: Dr. Gennaro Sardella
- Topic 1: RESET
- Embargo lift: 8:00 AM on Saturday, March 24, 2012
- Topic 2: ACC Wrap-Up in Italian
Monday March 26, 2012
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. Henry P. Selker
- Topic: Results of the IMMEDIATE (Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care) Trial: A Double-Blind Randomized Controlled Trial of Intravenous Glucose, Insulin, and Potassium (GIK)for Acute Coronary Syndromes in Emergency Medical Services
- Embargo lift: 8:00 AM Tuesday, March 27, 2012
9:30 AM
9:30 AM - 10:00 AM
- Interviewee: Dr. Sergio Leonardi and Dr. Pierluigi Tricoci
- Topic: ACC Wrap-Up in Italian
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Professor Harvey White
- Topic: ACC Wrap-Up from a Pacific Rim Perspective
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
11:30 AM - 12:00 PM
- Interviewee: Dr. Basil Lewis
- Topic: ACC Wrap-Up in Hebrew
12:00 PM
12:00 PM - 12:30 PM
- Interviewee: Dr. Juan Gaspar
- Topic: ACC Wrap-Up in Spanish
12:30 PM
12:30 PM - 1:00 PM
- Interviewee: Dr. Hyo-Soo Kim
- Topic: Randomized Comparison of Adding Cilostazol Versus Doubling the Dose of Clopidogrel after Receiving Percutaneous Coronary Intervention: The HOST-ASSURE Randomized Trial
- Embargo lift: 8:00 AM Sunday, March 25, 2012
1:00 PM
1:00 PM - 1:30 PM
- Interviewee: Dr. Renato Lopes
- Topic 1: ACC Wrap-Up in Portuguese
- Topic 2: CHADS Subgroup Analysis from ARISTOTLE
- Embargo lift: Sunday, March 25, 2012
Tuesday March 27, 2012
8:00 AM
8:00 AM - 8:30 AM
- Interviewee: Dr. Paul Armstrong
- Topic: ACC Wrap-Up from a Canadian Perspective
8:30 AM
8:30 AM - 9:00 AM
- Interviewee: Dr. Sergio Leonardi and Dr. Aldo Pietro Maggioni
- Topic: ACC Wrap-Up in Italian
9:00 AM
OPEN TIME SLOT
9:30 AM
9:30 AM - 10:00 AM
- Interviewee: Dr. Freek W.A. Verheugt
- Topic: ACC Wrap-Up from a Dutch Perspective
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Dr. Stefan James
- Topic: ACC Wrap-Up from a Scandinavian Perspective
10:30 AM
OPEN TIME SLOT
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Hisao Ogawa
- Topic: ACC Wrap-Up in Japanese
11:30 AM
11:30 AM - 12:00 PM
- Interviewee: Dr. Sigmund Silber
- Topic: ACC Wrap-Up in German